Breast cancer recurrence
A microRNA Signature Associated with Early Recurrence in Breast Cancer.
... Using a Cox proportional hazard regression model, we also tested all possible combinations of different covariates (tumor subtype, patient age, tumor size, number of lymph nodes affected and the 5-miRNA signature) with ...
14
Consumo de alcohol y riesgo de cncer de mama
... alcohol- breast cancer association varies by stage of breast cancer detection is ...early breast cancer detection, a factor known to result in delayed detection of ...of ...
8
Breast cancer epidemiology: mammographic screening and molecular subtypes
... metastatic breast cancer and later for prevention of breast cancer development in women at high risk ...ER-positive breast cancer development ...of breast cancer ...
148
Tratamiento radioterápico del cáncer mama: estándares y nuevas tendencias Irradiación parcial acelerada de la mama
... of breast-conservation therapy, has well-established results with good cosmesis, and low ...ipsilateral breast cancer recurrence resides within close proximity to the original tumor ...whole ...
12
Individualización del tratamiento en el tumor vesical no músculo-invasivo según criterios clínicos y anatomopatológicos
... the recurrence and progression of non-muscle invasive bladder cancer (NMIBC) has been carried out by using a number of clinical and pathological tumour features ...previous recurrence rate, T ...
152
Beyond Breast Cancer In Later Life: Subjective Well-Being In Older Women With Breast Cancer In Remission
... out breast cancer, regarding subjective well-being (SWB); to assess the association of SWB with breast cancer; and to examine the association of the affective with the cognitive dimension of ...
8
A treatment decision model for breast cancer patients
... to Cancer Reserach UK (2013), the ...(2013), breast cancer treatments are generally composed of a primary treatment and followed by an adjuvant ...whole breast (mastectomy), only the lump area ...
20
Automated method to assist breast cancer diagnosis
... include breast density type. In this work we used the CBIS-DDSM (Curated Breast Imaging Subset of DDSM) is an updated and standardized version of the ...
80
Genetic Cancer Risk Assessment for Breast Cancer in Latin America
... genetic cancer counseling in Latin ...reditary Cancer Network (BHCN), which in 2011 pub- lished the first Brazilian guidelines for the detection, diagnosis, counseling, testing, and surveillance of he- ...
9
Social inequalities and mortality in Europe-results from a large multi-national cohort
... for cancer-related causes of death, in addition to, as one would expect, lung cancer in both ...with cancer mortality, as some of us have already shown for lung cancer ...
10
Structural elucidation and evaluation of multidrug-resistance modulatory capability of amarissinins A–C, diterpenes derived from Salvia amarissima
... human cancer cell lines: MCF-7 and MDA-MB-231 (mammary adenocarcinoma), HeLa (cervix carcinoma), HCT-15 and HCT- 116 (colon adenocarcinoma) cell lines, supplied by the National Cancer Institute (NCI, ...
27
Resilience and workability among breast cancer survivors
... with breast cancer will end up in permanent disability and 53% will return to work after one year since diagnosis (López-Guillén ...sis, breast cancer survivors have a ...sense, breast ...
8
Demora en pacientes colombianas con cncer de mama
... of breast cancer in Bogota, Colombia and examine the extent and de- terminants of patient ...recognize breast cancer ...regarding breast cancer symptoms and early ...
9
Aspectos psicológicos del cáncer de mama
... ASPECTOS PSICOLÓGICOS DEL CANCER DE MAMA Psychological aspects of breast cáncer.. Andrea Díaz Arango1, Lizeth Rodriguez Parales 2.[r] ...
27
Psychological Distress in Lithuanian Women with Breast Cancer
... El listado de problemas fue desarrollado por el Panel de Guías para el Manejo del malestar de la NCCN (National Comprehensive Cancer Network, 2003). Consiste en 34 problemas asociados con aflicciones comúnmente ...
8
Efecto del immunepotent CRP en la respuesta clínica e inmunológica en pacientes con cáncer de mama.
... an immunological agent that has been considered in the context of cancer immunotherapy is the dialyzable leuko- cyte extract (dlE) or transfer factor, which has no reported side effects or toxicity. DLE was irst ...
82
Endocrine disruptors as ligands of breast cancer proteins
... This study presents a virtual screening that helps to understand how endocrine disruptors could be plausible ligands for the breast cancer proteome. This approach provided important candidates to be ...
175
Variantes genticas de CYP1A1, CYP1B1, GSTM1 y GSTT1, y riesgo de cncer mamario en mujeres mexicanas
... Objective. To evaluate if variants in the genes CYP1A1 (T3801C and A4889G), CYP1B1 (G119T), GSTM1 (indel) and GSTT1 (indel) are associated with breast cancer (BC) among Mexican women. Materials and methods. ...
8
Invasive breast cancer Clinical, molecular and genetic aspects
... La edad promedio en que se diagnostica está en- tre los 58 y los 63 años de edad, a pesar de que el hombre puede desarrollar la condición a cualquier edad. El envejecimiento, la atrofia testicular, la infer- tilidad, una ...
27
Estudio de adherencia y seguridad en pacientes a tratamiento con capecitabina
... 5. Krolop L, Ko YD, Schwindt PF, Schumacher C, Fimmers R, Jaehde U. Adherence management for patients with cancer taking capeci- tabine: a prospective two-arm cohort study. BMJ Open. 2013; 3(7) 6. Gebbia V, ...
18
